GXMR-CAR containing distinct GXM-specific single-chain variable fragment (scFv) mediated the cell activation against Cryptococcus spp. And had difference in the strength of tonic signaling

References

• May RC, Stone NRH, Wiesner DL, et al. Cryptococcus: from environmental saprophyte to global pathogen. Nat Rev Microbiol. 2016;14(2):106. doi: 10.1038/nrmicro.2015.6
   PubMed Web of Science ®Google Scholar
• Skolnik K, Huston S, Mody CH. Cryptococcal Lung Infections. Clin Chest Med. 2017;38(3):451–26. doi: 10.1016/j.ccm.2017.04.007
   PubMed Web of Science ®Google Scholar
• Maziarz EK, Perfect JRIDCNA. Cryptococcosis. Infect Dis Clin North Am. 2016;30(1):179. doi: 10.1016/j.idc.2015.10.006
   PubMed Web of Science ®Google Scholar
• Harris J, Lockhart S, Chiller T. Cryptococcus gattii: where do we go from here? Med Mycol. 2012;50(2):113–129. doi: 10.3109/13693786.2011.607854
   PubMed Web of Science ®Google Scholar
• O’Halloran JA, Powderly WG, Spec A. Cryptococcosis today: it is not all about HIV infection. Curr Clin Microbiol Rep. 2017;4(2):88. doi: 10.1007/s40588-017-0064-8
   PubMed Web of Science ®Google Scholar
• Kozubowski L, Lee SC, Heitman J. Signalling pathways in the pathogenesis of Cryptococcus. Cell Microbiol. 2009;11(3):370–380. doi: 10.1111/j.1462-5822.2008.01273.x
   PubMed Web of Science ®Google Scholar
• Shourian M, Qureshi ST. Resistance and tolerance to cryptococcal infection: an intricate balance that controls the development of disease. Front Immunol. 2019;10:66. doi:10.3389/fimmu.2019.00066
   PubMed Web of Science ®Google Scholar
• Cherniak R, Valafar H, Morris LC, et al. Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network. Clin Diagn Lab Immunol. 1998;5(2):146–159. doi: 10.1128/CDLI.5.2.146-159.1998
   PubMedGoogle Scholar
• Cherniak R, Sundstrom JB. Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect Immun. 1994;62(5):1507. doi: 10.1128/iai.62.5.1507-1512.1994
   PubMed Web of Science ®Google Scholar
• Urai M, Kaneko Y, Ueno K, et al. Evasion of innate immune responses by the highly virulent Cryptococcus gattii by altering capsule glucuronoxylomannan structure. Front Cell Infect Microbiol. 2015;5:101. doi: 10.3389/fcimb.2015.00101
   PubMed Web of Science ®Google Scholar
• Ben-Abdallah M, Sturny-Leclère A, Avé P, et al. Fungal-induced cell cycle impairment, chromosome instability and apoptosis via differential activation of NF-κB. PLOS Pathog. 2012;8(3):e1002555. doi: 10.1371/journal.ppat.1002555
   PubMed Web of Science ®Google Scholar
• Chai LYA, Van De Veerdonk F, Marijnissen RJ, et al. Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity. Immunology. 2010;130(1):46. doi: 10.1111/j.1365-2567.2009.03211.x
   PubMed Web of Science ®Google Scholar
• Elsegeiny W, Marr KA, Williamson PR. Immunology of cryptococcal infections: developing a rational approach to patient therapy. Front Immunol. 2018;9:651. doi:10.3389/fimmu.2018.00651
   PubMed Web of Science ®Google Scholar
• Iyer KR, Revie NM, Fu C, et al. Treatment strategies for cryptococcal infection: challenges, advances and future outlook. Nat Rev Microbiol. 2021;19(7):454. doi: 10.1038/s41579-021-00511-0
   PubMed Web of Science ®Google Scholar
• da Silva TA, Hauser PJ, Bandey I, et al. Glucuronoxylomannan in the Cryptococcus species capsule as a target for Chimeric Antigen Receptor T-cell therapy. Cytotherapy. 2021;23(2):119–130. doi: 10.1016/j.jcyt.2020.11.002
   PubMed Web of Science ®Google Scholar
• dos Santos MH, Machado MP, Kumaresan PR, et al. Modification of hinge/transmembrane and signal transduction domains improves the expression and signaling threshold of GXMR-CAR specific to Cryptococcus spp. Cells. 2022;11(21):3386. doi: 10.3390/cells11213386
   PubMed Web of Science ®Google Scholar
• Fujiwara K, Masutani M, Tachibana M, et al. Impact of scFv structure in chimeric antigen receptor on receptor expression efficiency and antigen recognition properties. Biochem Biophys Res Commun. 2020;527(2):350–357. doi: 10.1016/j.bbrc.2020.03.071
   PubMed Web of Science ®Google Scholar
• Martinez LR, Moussai D, Casadevall A. Antibody to Cryptococcus neoformans glucuronoxylomannan inhibits the release of capsular antigen. Infect Immun. 2004;72(6):3674. doi: 10.1128/IAI.72.6.3674-3679.2004
   PubMed Web of Science ®Google Scholar
• Larsen RA, Pappas PG, Perfect J, et al. Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis. Antimicrob Agents Chemother. 2005;49(3):952–958. doi: 10.1128/AAC.49.3.952-958.2005
   PubMed Web of Science ®Google Scholar
• Casadevall A, Cleare W, Feldmesser M, et al. Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob Agents Chemother. 1998;42(6):1437. doi: 10.1128/AAC.42.6.1437
   PubMed Web of Science ®Google Scholar
• Casadevall A, Mukherjee J, Devi SJN, et al. Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. J Infect Dis. 1992;165(6):1086–1093. doi: 10.1093/infdis/165.6.1086
   PubMed Web of Science ®Google Scholar
• Wozniak KL, Levitz SM. Isolation and purification of antigenic components of Cryptococcus. Methods Mol Biol. 2009;470:71.
   PubMedGoogle Scholar
• Abraham MJ, Murtola T, Schulz R, et al. Gromacs: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1–2:19–25. doi: 10.1016/j.softx.2015.06.001
   Google Scholar
• Berendsen HJC, van der Spoel D, van Drunen R. GROMACS: a message-passing parallel molecular dynamics implementation. Comput Phys Commun. 1995;91(1–3):43–56. doi: 10.1016/0010-4655(95)00042-E
   Web of Science ®Google Scholar
• Hess B, Kutzner C, Van Der Spoel D, et al. GROMACS 4: algorithms for highly efficient, load-balanced, and scalable Molecular simulation. J Chem Theory Comput. 2008;4(3):435–447. doi: 10.1021/ct700301q
   PubMed Web of Science ®Google Scholar
• Pronk S, Páll S, Schulz R, et al. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics. 2013;29(7):845–854. doi: 10.1093/bioinformatics/btt055
   PubMed Web of Science ®Google Scholar
• Van Der Spoel D, Lindahl E, Hess B, et al. GROMACS: fast, flexible, and free. J Comput Chem. 2005;26(16):1701–1718. doi: 10.1002/jcc.20291
   PubMed Web of Science ®Google Scholar
• Huang J, Rauscher S, Nawrocki G, et al. charmm36m: an improved force field for folded and intrinsically disordered proteins. Nat Methods. 2016;14(1):71–73. doi: 10.1038/nmeth.4067
   PubMed Web of Science ®Google Scholar
• Young ACM, Valadon P, Casadevall A, et al. The three-dimensional structures of a polysaccharide binding antibody to Cryptococcus neoformans and its complex with a peptide from a phage display library: implications for the identification of peptide mimotopes. J Mol Biol. 1997;274(4):622–634. doi: 10.1006/jmbi.1997.1407
   PubMed Web of Science ®Google Scholar
• Baek M, DiMaio, F, Anishchenko, I, Dauparas, J, Ovchinnikov, S, Lee, G.R, Wang, J, Cong, Q., Kinch, L.N, Schaeffer, R.D Millán, C et al. Accurate prediction of protein structures and interactions using a three-track neural network. Sci (1979). 2021;373:871–876.
   PubMed Web of Science ®Google Scholar
• Anandakrishnan R, Aguilar B, Onufriev AV. H++ 3.0: automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations. Nucleic Acids Res. 2012;40(W1):W537–W541. doi: 10.1093/nar/gks375
   PubMed Web of Science ®Google Scholar
• Jorgensen WL, Chandrasekhar J, Madura JD, et al. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983;79(2):926–935. doi: 10.1063/1.445869
   Web of Science ®Google Scholar
• Hess B. P-LINCS: A Parallel Linear Constraint Solver for Molecular Simulation. J Chem Theory Comput. 2007;4(1):116–122. doi: 10.1021/ct700200b
   Web of Science ®Google Scholar
• Hess B, Bekker H, Berendsen HJC, et al. LINCS: A linear constraint solver for molecular simulations. J Comput Chem. 1997;18(12):1463–1472. doi: 10.1002/(SICI)1096-987X(199709)18:12<1463:AID-JCC4>3.0.CO;2-H
   Web of Science ®Google Scholar
• Miyamoto S, Kollman PAS. Settle: an analytical version of the SHAKE and RATTLE algorithm for rigid water models. J Comput Chem. 1992;13(8):952–962. doi: 10.1002/jcc.540130805
   Web of Science ®Google Scholar
• Essmann U, Perera L, Berkowitz ML, et al. A smooth particle mesh Ewald method. J Chem Phys. 1995;103(19):8577–8593. doi: 10.1063/1.470117
   Web of Science ®Google Scholar
• Haug EJ, Arora JS, Matsui K. A steepest-descent method for optimization of mechanical systems. J Optim Theory Appl. 1976;19(3):401–424. doi: 10.1007/BF00941484
   Web of Science ®Google Scholar
• Bussi G, Donadio D, Parrinello M. Canonical sampling through velocity rescaling. J Chem Phys. 2007;126(1). doi: 10.1063/1.2408420
   PubMed Web of Science ®Google Scholar
• Berendsen HJC, Postma JPM, Van Gunsteren WF, et al. Molecular dynamics with coupling to an external bath. J Chem Phys. 1984;81(8):3684–3690. doi: 10.1063/1.448118
   Web of Science ®Google Scholar
• Daura X, Gademann K, Jaun B, et al. Peptide folding: when simulation meets experiment. Angew Chem Int Ed Engl. 1999;38(1–2):236–240. doi: 10.1002/(SICI)1521-3773(19990115)38:1/2<236:AID-ANIE236>3.0.CO;2-M
   Web of Science ®Google Scholar
• Honorato RV, Koukos PI, Jiménez-García B, et al. Structural Biology in the clouds: the WeNMR-EOSC ecosystem. Front Mol Biosci. 2021;8:729513. doi: 10.3389/fmolb.2021.729513
   PubMed Web of Science ®Google Scholar
• Hess B, Kutzner C, Van Der Spoel D, et al. GROMACS 4: algorithms for highly efficient, load-balanced, and scalable Molecular simulation. 2008. doi: 10.1021/ct700301q
   Google Scholar
• Pronk S, Páll S, Schulz R, et al. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics. 2013;29(7):845. doi: 10.1093/bioinformatics/btt055
   PubMed Web of Science ®Google Scholar
• Van Der Spoel D, Lindahl E, Hess B, et al. GROMACS: fast, flexible, and free. J Comput Chem. 2005;26(16):1701–1718. doi: 10.1002/jcc.20291
   PubMed Web of Science ®Google Scholar
• Berendsen HJC, Postma JPM, van Gunsteren WF, et al. Interaction models for water in relation to protein hydration. 1981;pp. 331–342. doi: 10.1007/978-94-015-7658-1_21
   Google Scholar
• Van Zundert GCP, Rodrigues JPGLM, Trellet M, et al. The HADDOCK2.2 web server: user-friendly integrative modeling of biomolecular complexes. J Mol Biol. 2016;428(4):720–725. doi: 10.1016/j.jmb.2015.09.014
   PubMed Web of Science ®Google Scholar
• Zhang H, Hu Y, Shao M, et al. Dasatinib enhances anti-leukemia efficacy of chimeric antigen receptor T cells by inhibiting cell differentiation and exhaustion. J Hematol Oncol. 2021;14(1). doi: 10.1186/s13045-021-01117-y
   Web of Science ®Google Scholar
• Bongomin F, Gago S, Oladele RO, et al. Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision. Journal Of Fungi. 2017;3(4):57. doi: 10.3390/jof3040057
   Web of Science ®Google Scholar
• Dos Santos MH, Machado MP, Kumaresan PR, et al. Titan cells and yeast forms of Cryptococcus neoformans and Cryptococcus gattii are recognized by GXMR-CAR. Microorganisms. 2021;9(9):1886. doi: 10.3390/microorganisms9091886
   PubMed Web of Science ®Google Scholar
• Seif M, Kakoschke TK, Ebel F, et al. CAR T cells targeting Aspergillus fumigatus are effective at treating invasive pulmonary aspergillosis in preclinical models. Sci Transl Med. 2022;14(664). doi: 10.1126/scitranslmed.abh1209
   PubMed Web of Science ®Google Scholar
• Kumaresan PR, Manuri PR, Albert ND, et al. Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection. Proc Natl Acad Sci U S A. 2014;111(29):10660–10665. doi: 10.1073/pnas.1312789111
   PubMed Web of Science ®Google Scholar
• Ajina A, Maher J. Strategies to address chimeric antigen receptor tonic signalling. Mol Cancer Ther. 2018;17(9):1795. doi: 10.1158/1535-7163.MCT-17-1097
   PubMed Web of Science ®Google Scholar
• Sommermeyer D, Hill T, Shamah SM, et al. Fully human CD19-specific chimeric antigen receptors for T-cell therapy. Leukemia. 2017;31(10):2191. doi: 10.1038/leu.2017.57
   PubMed Web of Science ®Google Scholar
• Landoni E, Fucá G, Wang J, et al. Modifications to the framework regions eliminate chimeric antigen receptor tonic signaling. Cancer Immunol Res. 2021;9(4):441–453. doi: 10.1158/2326-6066.CIR-20-0451
   PubMed Web of Science ®Google Scholar
• Milone MC, Fish JD, Carpenito C, et al. Chimeric Receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo. Mol Ther. 2009;17(8):1453. doi: 10.1038/mt.2009.83
   PubMed Web of Science ®Google Scholar
• Gomes-Silva D, Mukherjee M, Srinivasan M, et al. Tonic 4-1BB costimulation in chimeric antigen receptors impedes T cell survival and is vector dependent. Cell Rep. 2017;21(1):17. doi: 10.1016/j.celrep.2017.09.015
   PubMed Web of Science ®Google Scholar
• Ostrand-Rosenberg S, Horn LA, Haile ST. The programmed death-1 immune suppressive pathway: barrier to anti-tumor immunity. J Immunol. 2014;193(8):3835. doi: 10.4049/jimmunol.1401572
   PubMed Web of Science ®Google Scholar
• Weber EW, Lynn RC, Sotillo E, et al. Pharmacologic control of CAR-T cell function using dasatinib. Blood Adv. 2019;3(5):711. doi: 10.1182/bloodadvances.2018028720
   PubMed Web of Science ®Google Scholar
• Bloemberg D, Nguyen T, MacLean S, et al. A high-throughput method for characterizing novel chimeric antigen receptors in Jurkat cells. Mol Ther Methods Clin Dev. 2020;16:238–254. doi: 10.1016/j.omtm.2020.01.012
   PubMed Web of Science ®Google Scholar